Publications by Past and Present Trainees

(Residents are indicated in bold. Students are indicated in underline. Fellows are indicated in italics.)

  1. Auerbach MS, Livhits MJ, Yu R. Pheochromocytomatosis Treated With Peptide Receptor Radionuclide Therapy. Clin Nucl Med. 2022 Jan 11.
  2. Hu QL, Schumm MA, Zanocco KA, Yeh MW, Livhits MJ, Wu JX. Cost analysis of reflexive versus selective molecular testing for indeterminate thyroid nodules. Surgery. 2022 Jan;171(1):147-154.
  3. Schumm MA, Nguyen DT, Kim J, Tseng CH, Chow AY, Shen N, Livhits MJ. Longitudinal Assessment of Quality of Life Following Molecular Testing for Indeterminate Thyroid Nodules. Ann Surg Oncol. 2021 Dec;28(13):8872-8881.
  4. Schumm MA, Livhits MJ. ASO Author Reflections: Improving the Quality of Life of Patients with Indeterminate Thyroid Nodules Receiving Molecular Testing. Ann Surg Oncol. 2021 Dec;28(13):8882-8883.
  5. Dawood NB, Tseng CH, Nguyen DT, Yan KL, Livhits MJ, Leung AM, Yeh MW. Systems-Level Opportunities in the Management of Primary Hyperparathyroidism: An Informatics-based Assessment. J Clin Endocrinol Metab. 2021 Nov 19;106(12):e4993-e5000.
  6. Zhu CY, Schumm MA, Hu TX, Nguyen DT, Kim J, Tseng CH, Lin AY, Yeh MW, Livhits MJ, Wu JX. Patient-Centered Decision-making for Postoperative Narcotic-Free Endocrine Surgery: A Randomized Clinical Trial. JAMA Surg. 2021 Nov 1;156(11):e214287.
  7. Fackelmayer OJ, Wu JX, Yeh MW. Endocrine Surgery: Management of Postoperative Complications Following Endocrine Surgery of the Neck. Surg Clin North Am. 2021 Oct;101(5):767-784.
  8. Acín-Perez R, Petcherski A, Veliova M, Benador IY, Assali EA, Colleluori G, Cinti S, Brownstein AJ, Baghdasarian S, Livhits MJ, Yeh MW, Krishnan KC, Vergnes L, Winn NC, Padilla J, Liesa M, Sacks HS, Shirihai OS. Recruitment and remodeling of peridroplet mitochondria in human adipose tissue. Redox Biol. 2021 Oct;46:102087.
  9. Hu MI, Waguespack SG, Dosiou C, Ladenson PW, Livhits MJ, Wirth LJ, Sadow PM, Krane JF, Stack BC, Zafereo ME, Ali SZ, Weitzman SP, Hao Y, Babiarz JE, Kennedy GC, Kloos RT. Afirma Genomic Sequencing Classifier and Xpression Atlas Molecular Findings in Consecutive Bethesda III-VI Thyroid Nodules. J Clin Endocrinol Metab. 2021 Jul 13;106(8):2198-2207.
  10. Ochoa JE, Socik AJ, Yeh MW, Wu JX. Perioperative pain management for thyroid and parathyroid surgery: A systematic review. Am J Surg. 2021 Jul 8:S0002-9610(21)00348-2.
  11. Schumm MA, Lechner MG, Shu ML, Ochoa JE, Kim J, Tseng CH, Leung AM, Yeh MW. Frequency of Thyroid Hormone Replacement After Lobectomy for Differentiated Thyroid Cancer. Endocr Pract. 2021 Jul;27(7):691-697.
  12. Schumm MA, Pyo HQ, Ohev-Shalom R, Tseng CH, Livhits MJ, Zanocco KA, Hiyama DT, Yeh MW. Patient experience with electronic health record-integrated postoperative telemedicine visits in an academic endocrine surgery program. Surgery. 2021 May;169(5):1139-1144.
  13. Tsai K, Yu AC, Livhits MJ, Sajed D, Leung AM, Cheung DS. Systemic light-chain amyloidosis incidentally diagnosed after subtotal parathyroidectomy and thyroid lobectomy. BMJ Case Rep. 2021 Apr 19;14(4):e241282.
  14. Tang AL, Kloos RT, Aunins B, Holm TM, Roth MY, Yeh MW, Randolph GW, Tabangin ME, Altaye M, Steward DL. Pathologic Features Associated With Molecular Subtypes of Well-Differentiated Thyroid Cancer. Endocr Pract. 2021 Mar;27(3):206-211.  
  15. Zhu CY, Donangelo I, Gupta D, Nguyen DT, Ochoa JE, Yeh MW, Livhits MJ. Outcomes of Indeterminate Thyroid Nodules Managed Nonoperatively after Molecular Testing. J Clin Endocrinol Metab. 2021 Mar 8;106(3):e1240-e1247.
  16. Schumm MA, Ohev-Shalom R, Nguyen DT, Kim J, Tseng CH, Zanocco KA. Measuring patient perceptions of surgeon communication performance in the treatment of thyroid nodules and thyroid cancer using the communication assessment tool. Surgery. 2021 Feb;169(2):282-288.
  17. Livhits MJ, Zhu CY, Kuo EJ, Nguyen DT, Kim J, Tseng CH, Leung AM, Rao J, Levin M, Douek ML, Beckett KR, Cheung DS, Gofnung YA, Smooke-Praw S, Yeh MW. Effectiveness of Molecular Testing Techniques for Diagnosis of Indeterminate Thyroid Nodules: A Randomized Clinical Trial. JAMA Oncol. 2021 Jan 1;7(1):70-77.
  18. Chin PD, Zhu CY, Sajed DP, Fishbein GA, Yeh MW, Leung AM, Livhits MJ. Correlation of ThyroSeq Results with Surgical Histopathology in Cytologically Indeterminate Thyroid Nodules. Endocr Pathol. 2020 Dec;31(4):377-384.
  19. Dawood NB, Yan KL, Shieh A, Livhits MJ, Yeh MW, Leung AM. Normocalcaemic primary hyperparathyroidism: An update on diagnostic and management challenges. Clin Endocrinol (Oxf). 2020 Nov;93(5):519-527.
  20. Yeh MW. Response to Galofré re: "The Year in Surgical Thyroidology". Thyroid. 2020 Aug;30(8):1222-1223.
  21. Wang MM, Beckett K, Douek M, Masamed R, Patel M, Tseng CH, Yeh MW, Leung AM, Livhits MJ. Diagnostic Value of Molecular Testing in Sonographically Suspicious Thyroid Nodules. J Endocr Soc. 2020 Jun 20;4(9):bvaa081.
  22. Schumm MAChilders CP, Wu JX, Zanocco KA. Cost Saving of Short Hospitalization Nonoperative Management for Acute Uncomplicated Appendicitis J Surg Res. 2020 Jun 15;255:77-85.
  23. Zhu CY, Sha SW, Tseng CH, Yang SE, Orr LE, Levin M, Wong CW, Livhits MJ, Yeh MW. Trends in the Surgical Management of Known or Suspected Differentiated Thyroid Cancer at a Single Institution, 2010 – 2018. Thyroid. 2020 Jun 9; epub ahead of print.
  24. Wong CW, Schumm MA, Zhu CY, Tseng CH, Arasu A, Han J, Livhits MJ. Quality of Life Following Molecular Marker Testing for Indeterminate Thyroid Nodules. Endocr Pract. 2020 May 14; epub ahead of print.
  25. Mederos MA, Orr LE, Livhits MJ, Rigberg DA. Management of Acute Limb Ischemia Related to Underlying Pheochromocytoma. J Vasc Surg Cases Innov Tech. 2020 Apr 15;6(2):272-276
  26. Yan KL, Li S, Tseng CH, Kim J, Nguyen DT, Dawood NB, Livhits MJ, Yeh MW, Leung AM. Rising Incidence and Incidence-Based Mortality of Thyroid Cancer in California, 2000-2017. JCEM. 2020 Mar 13.105(6).
  27. Zhu CY, Sturgeon C, Yeh MW. Diagnosis and Management of Primary Hyperparathyroidism. JAMA. 2020 Feb 7; epub ahead of print.
  28. Zanocco KA, Wang MM, Yeh MW, Livhits MJ. Selective use of Molecular Testing Based on Sonographic Features of Cytologically Indeterminate Thyroid Nodules: A Decision Analysis. World J Surg. 2020 Feb;44(2):393-401.
  29. Orr LE, Zhou H, Zhu CY, Haigh PI, Adams AL, Yeh MW. Skeletal effects of combined medical and surgical management of primary hyperparathyroidism. Surgery. 2020 Jan;167(1):144-148.
  30. Hu QL, Livhits MJ, Ko CY, Yeh MW. Same-day discharge is not associated with increased readmissions or complications after thyroid operations. Surgery. 2020 Jan;167(1):117-123.
  31. Nguyen-Lee JJ, Paciuc M, Guerra R, Esnaola N, Zanocco KA, Zheng F. Derivation of a cost-saving screening strategy for asymptomatic primary hyperparathyroidism. Surgery. 2020 Jan;167(1):155-159.
  32. Madani A, Grover K, Kuo JH, Mitmaker EJ, Shen W, Beninato T, Livhits M, Smith PW, Miller BS, Sippel RS, Duh QY, Lee JA. Defining the competencies for laparoscopic transabdominal adrenalectomy: An investigation of intraoperative behaviors and decisions of experts. Surgery. 2020 Jan;167(1):241-249.
  33. Shirali AS, Wu JXZhu CY, Ocampo A, Tseng CH, Du L, Livhits MJ, Leung AM, Yeh MW. The role of serum procalcitonin in predicting bacterial sepsis in patients with hypothyroidism. J Clin Endocrinol Metab. 2019 Dec 1;104(12):5915-5922.
  34. Zhu CY, Nguyen DT, Yeh MW. Who Benefits from Treatment of Primary Hyperparathyroidism? Surg Clin North Am. Aug 2019;99(4):667-679.
  35. Yeh MW, Zhou H, Kuo EJ, Adams AL, Li N, Haigh PI. Biochemical dynamics of untreated primary hyperparathyroidism: an observational study. Endocrinology Practice. 2019 May; 25(5):470-476
  36. Fallah R, Du L, Braverman LE, He X, Segura-Harrison M, Yeh MW, Pearce EN, Chiu HK, Mittelman SD, Leung AM. iodine nutrition in weaning infants in the United States. Thyroid. 2019 Apr; 29(4):573-576
  37. Zheng F, Park KW, Thi WJ, Ro CC, Bass BL, Yeh MW. financial implications of telemedicine visits in an academic endocrine surgery program. Surgery. 2019 Mar; 165(3):617-621
  38. Sho SKuo EJ, Chen AC, Li N, Yeh MW, Livhits MJ. Biochemical and skeletal outcomes of parathyroidectomy for normocalcemic (incipient) primary hyperparathyroidism. Ann Surg Onc. 2019 Feb; 26(2):539-546.
  39. Lee JD, Kuo EJ, Du L, Yeh MW, Livhits MJ. Risk factors for readmission after parathyroidectomy for renal hyperparathyroidism, World J Surg. 2019 Feb; 43(2):534-539
  40. Assadipour Y, Zhou H, Kuo EJ, Haigh PI, Adams AL, Yeh MW. End-organ effects of primary hyperparathyroidism: A population-based study. Surgery. 2019 Jan; 165(1):99-104.
  41. Kuo EJ, Al-Alusi MA, Du L, Shieh A, Livhits MJ, Leung AM, Yeh MW. Surgery for Primary Hyperparathyroidism: Adherence to Consensus Guidelines in an Academic Health System. Annals of Surgery. 2019 Jan; 269(1):158-162.
  42. Kuo EJWu JX, Zanocco KA. Cost Effectiveness of Immediate Biopsy Versus Surveillance of Intermediate-Suspicion Thyroid Nodules. Surgery. 2018 Dec;164(6):1330-1335.
  43. Hung ML, Wu JX, Li N, Livhits MJ, Yeh MW. Association of radioactive iodine administration after reoperation with outcomes among patients with recurrent or persistent papillary thyroid cancer. JAMA Surg. 2018 Aug 15; 153(12):1098-1104.
  44. Ro K, Yuen AD, Du L, Ro CC, Seger C, Yeh MW, Leung AM, Rhee CM. Impact of hypothyroidism and heart failure on hospitalization risk. Thyroid. 2018 Jul 27; 28(9):1094-1100.
  45. Livhits MJ, Kuo EJ, Leung AM, Rao J, Levin M, Douek ML, Beckett KR, Zanocco KA, Cheung DS, Gofnung YA, Smooke-Praw S, Yeh MW. Gene Expression Classifier vs Targeted Next-Generation Sequencing in the management of indeterminate thyroid nodules. J Clin Endocrinol Metab. 2018 Jun 1;103(6):2261-2268.
  46. Zanocco K, Kaltman DJ, Wu JX, Fingeret A, Heller KS, Lee JA, Yeh MW, Sosa JA, Sturgeon C. Cost Effectiveness of Routine Laryngoscopy in the Surgical Treatment of Differentiated Thyroid Cancer. Ann Surg Oncol. 2018 Apr;25(4):949-956.
  47. Park KW, Wu JX, Du L, Leung AM, Yeh MW, Livhits MJ. Decreasing Use of Radioactive Iodine for Low-Risk Thyroid Cancer in California, 1999 to 2015. J Clin Endocrinol Metab. 2018 Mar 1;103(3):1095-1101.
  48. Zheng F, Zhou H, Li N, Haigh PI, Adams AL, Yeh MW. Skeletal effects of failed parathyroidectomy. Surgery. 2018 Jan;163(1):17-21.
  49. Chen AC, Livhits MJ, Du L, Wu JXKuo EJ, Yeh MW, Leung AM. Recent Pregnancy Is Not Associated with High-Risk Pathological Features of Well-Differentiated Thyroid Cancer. Thyroid. 2018 Jan;28(1):68-71.
  50. Kuo EJSho S, Li N, Zanocco KA, Yeh MW, Livhits MJ. Risk Factors Associated With Reoperation and Disease-Specific Mortality in Patients With Medullary Thyroid Carcinoma. JAMA Surg. 2018 Jan 1;153(1):52-59.
  51. Kuo EJ, Thi WJ, Zheng F, Zanocco KA, Livhits MJ, Yeh MW. Individualizing Surgery in Papillary Thyroid Carcinoma Based on a Detailed Sonographic Assessment of Extrathyroidal Extension. Thyroid. 2017 Dec;27(12):1544-1549.
  52. Sho S, Yuen AD, Yeh MW, Livhits MJ, Sepahdari AR. Factors Associated With Discordance Between Preoperative Parathyroid 4-Dimensional Computed Tomographic Scans and Intraoperative Findings During Parathyroidectomy. JAMA Surg. 2017 Dec 1;152(12):1141-1147.
  53. Assadipour Y, Yeh MW, Livhits MJ. Most low-risk papillary thyroid cancers remain stable during active surveillance. Clinical thyroidology. 2017 October; 29(10):368-370.
  54. Sho S, Singer ES, Kwok E, Hissom R, Harari A, Livhits MJ, Yeh MW. Sustained Growth of a University-Based Endocrine Surgery Program Over 10 Years. Ann Surg Oncol. 2017 Oct;24(11):3306-3311.
  55. Kuo EJWu JX, Li N, Zanocco KA, Yeh MW, Livhits MJ. Nonoperative Management of Differentiated Thyroid Cancer in California: A Population-Level Analysis of 29,978 Patients. Endocr Pract. 2017 Oct;23(10):1262-1269.
  56. Kuo EJ, Al-Alusi MA, Du L, Shieh A, Livhits MJ, Leung AM, Yeh MW. Surgery for Primary Hyperparathyroidism: Adherence to Consensus Guidelines in an Academic Health System. Ann Surg. 2017 Aug 11.
  57. Sho S, Yeh MW, Li N, Livhits MJ. Single-incision retroperitoneoscopic adrenalectomy: a North American experience. Surg Endosc. 2017 Jul;31(7):3014-3019.
  58. Kuo EJ, Sisk AE, Yang Z, Huang J, Yeh MW, Livhits MJ. Adrenal Teratoma: a Case Series and Review of the Literature. Endocr Pathol. 2017 Jun;28(2):152-158.
  59. Seger CD, He X, Braverman LE, Yeh MW, Bernet VJ, Singh RJ, Rhee CM, Leung AM. Negligible Thyroid Hormone Content Present in Nonprescription U.S. Weight Loss Products. Thyroid. 2017 Feb;27(2):300-301.
  60. Zanocco KA, Wu JX, Yeh MW. Parathyroidectomy for asymptomatic primary hyperparathyroidism: A revised cost-effectiveness analysis incorporating fracture risk reduction. Surgery. 2017 Jan;161(1):16-24.
  61. Sho S, Yilma M, Yeh MW, Livhits M, Wu JX, Hoang JK, Sepahdari AR. Prospective Validation of Two 4D-CT-Based Scoring Systems for Prediction of Multigland Disease in Primary Hyperparathyroidism. AJNR Am J Neuroradiol. 2016 Dec;37(12):2323-2327.
  62. Young S, Wu JX, Li N, Yeh MW, Livhits MJ. More Extensive Surgery May Not Improve Survival Over Parathyroidectomy Alone in Parathyroid Carcinoma. Ann Surg Oncol. 2016 Sep;23(9):2898-904.
  63. Wu JX, Young S, Hung ML, Li N, Yang SE, Cheung DS, Yeh MW, Livhits MJ. Clinical Factors Influencing the Performance of Gene Expression Classifier Testing in Indeterminate Thyroid Nodules. Thyroid. 2016 Jul;26(7):916-22.
  64. Barr ML, Chiu HK, Li N, Yeh MW, Rhee CM, Casillas J, Iskander PJ, Leung AM. Thyroid Dysfunction in Children Exposed to Iodinated Contrast Media. J Clin Endocrinol Metab. 2016 Jun;101(6):2366-70.
  65. Wu JX, Yeh MW. Asymptomatic Primary Hyperparathyroidism: Diagnostic Pitfalls and Surgical Intervention. Surg Oncol Clin N Am. 2016 Jan;25(1):77-90.
  66. Wu JX, Lam R, Levin M, Rao J, Sullivan PS, Yeh MW. Effect of malignancy rates on cost-effectiveness of routine gene expression classifier testing for indeterminate thyroid nodules. Surgery. 2016 Jan;159(1):118-26.
  67. Cham S, Sepahdari AR, Hall KE, Yeh MW, Harari A. Dynamic Parathyroid Computed Tomography (4DCT) Facilitates Reoperative Parathyroidectomy and Enables Cure of Missed Hyperplasia. Ann Surg Oncol. 2015 Oct;22(11):3537-42.
  68. Al-Alusi MA, Du L, Li N, Yeh MW, He X, Braverman LE, Leung AM. Metformin Does Not Suppress Serum Thyrotropin by Increasing Levothyroxine Absorption. Thyroid. 2015 Oct;25(10):1080-4.
  69. Villa NM, Li N, Yeh MW, Hurvitz SA, Dawson NA, Leung AM. Serum thyrotropin concentrations are not predictive of aggressive breast cancer biology in euthyroid individuals. Endocr Pract. 2015 Sep;21(9):1040-5.
  70. Wu JX, Beni CE, Zanocco KA, Sturgeon C, Yeh MW. Cost-Effectiveness of Long-Term Every Three-Year Versus Annual Postoperative Surveillance for Low-Risk Papillary Thyroid Cancer. Thyroid. 2015 Jul;25(7):797-803.
  71. Wu JX, Young S, Ro K, Li N, Leung AM, Chiu HK, Harari A, Yeh MW. Reproductive outcomes and nononcologic complications after radioactive iodine ablation for well-differentiated thyroid cancer. Thyroid. 2015 Jan;25(1):133-8.
  72. Livhits M, Li N, Yeh MW, Harari A. Surgery is associated with improved survival for adrenocortical cancer, even in metastatic disease. Surgery. 2014 Dec;156(6):1531-41.
  73. Abdulla AG, Ituarte PH, Harari A, Wu JX, Yeh MW. Trends in the Frequency and Quality of Parathyroid Surgery: Analysis of 17,082 Cases Over 10 Years. Ann Surg. 2014 Jun 19.
  74. Frank PN, Palma Diaz MF, Uslan DZ, Yeh MW. Histoplasmosis mimicking malignant adenopathy during diagnostic thyroid lobectomy. JAMA Otolaryngol Head Neck Surg. 2014 Jul;140(7):664-6.
  75. Maletkovic J, Isorena JP, Palma Diaz MF, Korenman SG, Yeh MW. Multifactorial hypercalcemia and literature review on primary hyperparathyroidism associated with lymphoma. Case Rep Endocrinol. 2014;2014:893134.
  76. Cham S, Zanocco K, Sturgeon C, Yeh MW, Harari A. Risk-based ultrasound screening for thyroid cancer in obese patients is cost-effective. Thyroid. 2014 Jun;24(6):975-86.
  77. Smooke-Praw S, Ro K, Levin O, Ituarte PH, Harari A, Yeh MW. Thyroglobulin antibody levels do not predict disease status in papillary thyroid cancer. Clin Endocrinol (Oxf). 2014 Aug;81(2):271-5.
  78. Young S, Harari A, Smooke-Praw S, Ituarte PH, Yeh MW. Effect of reoperation on outcomes in papillary thyroid cancer. Surgery. 2013 Dec;154(6):1354-61.
  79. Edling KL, Korenman SG, Janzen C, Sohsman MY, Apple SK, Bhuta S, Yeh MW. A pregnant dilemma: primary hyperparathyroidism due to parathyromatosis in pregnancy. Endocr Pract. 2014 Feb;20(2):e14-7.
  80. Abdulla AG, O’Leary E, Palma Diaz MF, Yeh MW. Recurrent hyperparathyroidism and a novel missense mutation in a patient with hyperparathyroidism-jaw tumor syndrome. Endocr Pract. 2013 Nov-Dec;19(6):e134-7.
  81. Yeh MW, Ituarte PH, Zhou HC, Nishimoto S, Liu IL, Harari A, Haigh PI, Adams AL. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab. 2013;98(3):1122-9.
  82. Wiseman JE, Ituarte PH, Ro K, Pasternak JD, Quach CA, Tillou AK, Hines OJ, Hiatt JR, Yeh MW. The effect of a dedicated endocrine surgery program on general surgery training: a single institutional experience. Am J Surg. 2012;203(6):782-4.
  83. Morris LF, Loh C, Ro K, Wiseman JE, Gomes AS, Asandra A, Wariri S, Yeh MW. Non-super-selective venous sampling for persistent hyperparathyroidism using a systemic hypocalcemic challenge. J Vasc Interv Radiol. 2012;23(9):1191-9.
  84. Harari A, Endo B, Nishimoto S, Ituarte PH, Yeh MW. Risk of advanced papillary thyroid cancer in obese patients. Arch Surg. 2012;147(9):805-11.
  85. Gier B, Butler PC, Lai CK, Kirakossian D, DeNicola MM, Yeh MW. Glucagon like peptide-1 receptor expression in the human thyroid gland. J Clin Endocrinol Metab. 2012;97(1):121-31.
  86. Abdulla AG, Ituarte PH, Wiggins R, Teisberg EO, Harari A, Yeh MW. Endocrine surgery as a model for value-based health care delivery. Surg Neurol Int. 2012;3:163.
  87. Han JY, Mirsadraei L, Yeh MW, Suh JD, Yong WH, Bergsneider M, Heaney AP. Bilateral adrenalectomy: lifesaving procedure in severe cushing syndrome. Endocr Pract. 2012 Jul 1;18(4):e85-90.
  88. Yeh MW, Wiseman JE, Ituarte PH, Pasternak JD, Hwang RS, Liu IL, Haigh PI. Surgery for primary hyperparathyroidism: Are the consensus guidelines being followed? Ann Surg. 2012 Jun;255(6):1179-83.
  89. Patterson ME, Mao CS, Yeh MW, Ipp E, Cortina G, Barank D, Vasinrapee P, Pawlikowska-Haddal A, Lee WN, Yee JK. Hyperinsulinism presenting in childhood and treatment by conservative pancreatectomy. Endocr Pract. 2012 May-Jun;18(3):e52-6.
  90. Yeh MW, Wiseman JE, Chu SD, Ituarte PH, Harari A, Liu IL, Haigh PI. Population-level predictors of persistent and recurrent hyperparathyroidism. Surgery. 2011 Dec;150(6):1113-9.
  91. Hong JC, Morris LF, Park EJ, Ituarte PH, Lee CH, Yeh MW. Transient elevations in intra-operative PTH levels related to anesthetic technique. Surgery. 2011 Dec;150(6):1069-75.
  92. Popadich A, Levin O, Smooke-Praw S, Ro K, Fazel M, Arora A, Tolley MS, Pallazzo FF, Learoyd DL, Sidhu S, Delbridge L, Sywak M, Yeh MW. A Multicenter Cohort Study of Total Thyroidectomy and Routine Central Lymph Node Dissection for cN0 Papillary thyroid cancer. Surgery. 2011 Dec;150(6):1048-57.
  93. Ro K, Cameron JL, Yeh MW. The Hunterian Laboratory of Experimental Medicine. Ann Surg. 2011;253(5):1042-8.
  94. Nguyen J, Abemayor A, and Yeh MW. Undescended parathyroid adenoma arising within the hypoglossal nerve. Arch Otolaryngol Head Neck Surg. 2011 Jul;137(7):709-11.
  95. Wiseman JE, Ituarte PH, Hwang RS, Safir I, Pasternak JD, Van Nuys K, Yeh MW. Strategic Impact of a New Academic Endocrine Surgery Program. Ann Surg Oncol. 2011 Feb 23. [Epub ahead of print] PubMed PMID: 21347789.
  96. Morris LF, Park S, Daskivich T, Churchill BM, Rao CV, Lei Z, Martinez D, Yeh MW. Virilization of a Female Infant by a Maternal Adrenocortical Carcinoma. Endocr Pract. 2011 Feb 16:1-18. [Epub ahead of print] PubMed PMID: 21324830.
  97. Levin O, Morris LF, Wah DT, Butch AW, Yeh MW. Falsely elevated plasma parathyroid hormone (PTH) mimicking tertiary hyperparathyroidism. Endocr Pract. 2011 Jan 17:1-12. [Epub ahead of print] PubMed PMID: 21247852.
  98. Morris LF, Zelada J, Wu B, Hahn TJ, Yeh MW. Parathyroid surgery in the elderly. Oncologist. 2010;15(12):1273-84. Epub 2010 Dec 15. PubMed PMID: 21159725.
  99. Kulkarni RP, Ituarte PH, Gunderson D, Yeh MW. Clinical pathways improve hospital resource use in endocrine surgery. J Am Coll Surg. 2011 Jan;212(1):35-41. Epub 2010 Nov 30. PubMed PMID: 21123093.
  100.  Wu B, Haigh PI, Hwang R, Ituarte PH, Liu IL, Hahn TJ, Yeh MW. Underutilization of parathyroidectomy in elderly patients with primary hyperparathyroidism. J Clin Endocrinol Metab. 2010 Sep;95(9):4324-30. Epub 2010 Jul 7. PubMed PMID: 20610600; PubMed Central PMCID: PMC2936062.
  101.  Hwang RS, Morris LF, Ro K, Park S, Ituarte PH, Hong JC, Yeh MW. A selective, Bayesian approach to intraoperative PTH monitoring. Ann Surg. 2010 Jun;251(6):1122-6. PubMed PMID: 20485138.
  102.  Wiseman JE, Mossanen M, Ituarte PH, Bath JM, Yeh MW. An algorithm informed by the parathyroid hormone level reduces hypocalcemic complications of thyroidectomy. World J Surg. 2010 Mar;34(3):532-7. PubMed PMID: 20049440; PubMed Central PMCID: PMC2816818.
  103.  Zarrinpar A, Yeh MW. Functional cortical neoplasms. Cancer Treat Res. 2010;153:163-86. Review. PubMed PMID: 19957225.
  104.  Morris LF, Zanocco K Ituarte PH, Ro K, Duh QY, Sturgeon C, Yeh MW. The value of intraoperative parathyroid hormone monitoring in localized primary hyperparathyroidism: a cost analysis. Ann Surg Oncol. 2010 Mar;17(3):679-85. Epub 2009 Nov 3. PubMed PMID: 19885701; PubMed Central PMCID: PMC2820694.
  105. Dhanasopon AP, Shemin RJ, Yeh MW. Cardiac paraganglioma presenting as gestational hypertension. Surgery. 2010 Mar;147(3):459-61. Epub 2008 Oct 11. PubMed PMID: 19744427.
  106. Lewis CE, Tillou A, Yeh MW, Quach C, Hiatt JR, Hines OJ. Web-based portfolios: a valuable tool for surgical education. J Surg Res. 2010 Jun 1;161(1):40-6. Epub 2009 Jan 1. PubMed PMID: 19345374.
  107. Imani F, Agopian VG, Auerbach MS, Walter MA, Imani F, Benz MR, Dumont RA, Lai CK, Czernin JG, Yeh MW. 18F-FDOPA PET and PET/CT accurately localize pheochromocytomas. J Nucl Med. 2009 Apr;50(4):513-9. Epub 2009 Mar 16. PubMed PMID: 19289420.
  108. Lewis CE, Yeh MW. Inherited endocrinopathies: an update. Mol Genet Metab. 2008 Jul;94(3):271-82. Epub 2008 Apr 22. Review. PubMed PMID: 18434223.
  109. Morris LF, Ragavendra N, Yeh MW. Evidence-based assessment of the role of ultrasonography in the management of benign thyroid nodules. World J Surg. 2008 Jul;32(7):1253-63. Review. PubMed PMID: 18311500.
  110.  Stavrakis AI, Ituarte PH, Ko CY, Yeh MW. Surgeon volume as a predictor of outcomes in inpatient and outpatient endocrine surgery. Surgery. 2007 Dec;142(6):887-99; discussion 887-99. Epub 2007 Oct 26. PubMed PMID: 18063073.
  111. Vardanian AJ, Hines OJ, Farrell JJ, Yeh MW. Incidentally discovered tumors of the endocrine glands. Future Oncol. 2007 Aug;3(4):463-74. Review. PubMed PMID: 17661721.